News
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: CANCOM SE: Q1 2025 results significantly below previous year's figure as expected; forecast for the full year 2025 confirmed
CANCOM SE reports Q1 2025 results below previous year's figures, confirms full year forecast due to improving market conditions. Preliminary figures show lower revenues and EBITDA -
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
THERANEXUS PUBLIE SES RÉSULTATS ANNUELS 2024, FAIT LE POINT SUR SES ACTIVITÉS ET CLÔTURE SA LIGNE DE FINANCEMENT
Theranexus publie ses résultats annuels 2024, fait le point sur ses activités et clôture sa ligne de financement. Détails sur Batten-1, PickASO, IMASO et partenariat avec Exeltis -
COMMUNIQUÉ DE PRESSE
THERANEXUS PUBLISHES ITS 2024 FULL-YEAR RESULTS, PRESENTS ITS PROGRESS REPORT AND CLOSES ITS EQUITY LINE
Theranexus publishes financial results for 2024 & cash position as of March 31, 2025, presents progress report & plans for Batten-1 drug candidate. Board approves accounts. Continues strategic partnerships & developments